Korro Bio, Inc.
KRRO
$14.48
$0.372.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.65% | 17.73% | 67.91% | 65.47% | 73.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.76% | 11.41% | 29.23% | 29.61% | 31.25% |
| Operating Income | -11.15% | -8.72% | -29.23% | -29.61% | -31.25% |
| Income Before Tax | -7.66% | -2.83% | -22.34% | -24.22% | -26.59% |
| Income Tax Expenses | 181.82% | 422.22% | 2.70% | 27.03% | 340.00% |
| Earnings from Continuing Operations | -7.75% | -2.97% | -22.33% | -24.23% | -26.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.75% | -2.97% | -22.33% | -24.23% | -26.64% |
| EBIT | -11.15% | -8.72% | -29.23% | -29.61% | -31.25% |
| EBITDA | -11.00% | -9.20% | -30.77% | -30.72% | -31.47% |
| EPS Basic | 93.07% | 95.44% | 94.15% | 47.34% | -68.75% |
| Normalized Basic EPS | 93.07% | 95.45% | 94.15% | 47.30% | -68.63% |
| EPS Diluted | 93.07% | 95.44% | 94.15% | 47.34% | -68.75% |
| Normalized Diluted EPS | 93.07% | 95.45% | 94.15% | 47.30% | -68.63% |
| Average Basic Shares Outstanding | 167.15% | 483.21% | 406.63% | 101.93% | -13.19% |
| Average Diluted Shares Outstanding | 167.15% | 483.21% | 406.63% | 101.93% | -13.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |